International Perfusion Association

Social:

Facebook Instagram Linkedin
IPA

Category: IABP

IABP 2024

A Multivariate and Retrospective Analysis of the Impact of Intra-Aortic Balloon Counterpulsation in Open-Heart Surgery

This retrospective study examined 1,114 cardiac surgical patients who required intra-aortic balloon pump (IABP) support between 2009 and 2018. Patients were divided into pre-operative, intra-operative, and post-operative IABP insertion groups. The overall mortality rate was 10.9%, highest postoperatively (25.8%). Predictors of mortality included age, BMI, pulmonary hypertension, renal disease, and cardiogenic shock. Complications, particularly renal issues, were common in post-operative IABP use. Pre-operative IABP prophylaxis may reduce mortality in high-risk cases.

READ MORE
December 1, 2024
IABP Cardiogenic Shock

The Intra-Aortic Balloon Pump as a Rescue Device: Do We Need to Shift Our Strategy for Cardiogenic Shock Rescue After Cardiac Surgery?

This study evaluates the efficacy of the intra-aortic balloon pump (IABP) as a rescue strategy for patients experiencing complications following cardiac surgery. Data from 10,591 patients between 2012 and 2020 were analyzed, revealing that IABP use is associated with increased early and one-year mortality, especially when deployed for more than four days or after cardiac arrest. The findings suggest alternative mechanical circulatory support methods may be more appropriate for severe cardiogenic shock.

READ MORE
September 28, 2024
ECMO China

Intra-Aortic Balloon Pump in VA-ECMO Patients: Insights from the Chinese Extracorporeal Life Support Registry

This study from the Chinese Extracorporeal Life Support (CSECLS) registry explored the effectiveness of using an intra-aortic balloon pump (IABP) alongside venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients undergoing treatment for refractory cardiogenic shock or cardiac arrest. Covering data from over 112 member centers, the study analyzed outcomes of 4,755 patients, comparing those who received VA-ECMO with IABP to those who did not. Findings indicated no significant difference in in-hospital mortality rates between the two groups, though IABP use was associated with higher incidences of continuous renal replacement therapy (CRRT) and limb ischemia. These results suggest that while IABP use does not reduce mortality in VA-ECMO patients, it may lead to increased complications, calling for further research and careful clinical decision-making.

READ MORE
March 26, 2024

Post Categories